These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8557786)

  • 1. Review of the initiation of anticoagulant therapy.
    Corbett NE; Peterson GM
    J Clin Pharm Ther; 1995 Aug; 20(4):221-4. PubMed ID: 8557786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shortened hospitalization by means of adjusted-dose subcutaneous heparin for deep venous thrombosis.
    Hirsch DR; Lee TH; Morrison RB; Carlson W; Goldhaber SZ
    Am Heart J; 1996 Feb; 131(2):276-80. PubMed ID: 8579021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges to the effective use of unfractionated heparin in the hospitalized management of acute thrombosis.
    Hylek EM; Regan S; Henault LE; Gardner M; Chan AT; Singer DE; Barry MJ
    Arch Intern Med; 2003 Mar; 163(5):621-7. PubMed ID: 12622610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.
    Carter BL; Jones ME; Waickman LA
    Clin Pharm; 1985; 4(3):279-96. PubMed ID: 3891200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
    Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
    J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of major hemorrhage in patients treated with unfractionated intravenous heparin for deep venous thrombosis or pulmonary embolism: a study in routine clinical practice.
    Zidane M; Schram MT; Planken EW; Molendijk WH; Rosendaal FR; van der Meer FJ; Huisman MV
    Arch Intern Med; 2000 Aug 14-28; 160(15):2369-73. PubMed ID: 10927736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Audit of anticoagulant therapy of pulmonary embolus, deep vein thrombosis and thrombophlebitis.
    Meinhold JM; Reale EO; Miller WA
    Am J Hosp Pharm; 1979 Feb; 36(2):214-8. PubMed ID: 420210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preprocedural therapeutic international normalized ratio influence on bleeding complications in atrial fibrillation ablation with continued anticoagulation with warfarin.
    Hayashi T; Kumagai K; Naito S; Goto K; Kaseno K; Ohshima S; Hachiya H; Hirao K; Isobe M
    Circ J; 2013; 77(2):338-44. PubMed ID: 23090638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal dosing of subcutaneous unfractionated heparin for the treatment of deep vein thrombosis.
    Kearon C; Harrison L; Crowther M; Ginsberg JS
    Thromb Res; 2000 Mar; 97(6):395-403. PubMed ID: 10704648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs.
    Caprini JA; Tapson VF; Hyers TM; Waldo AL; Wittkowsky AK; Friedman R; Colgan KJ; Shillington AC;
    J Vasc Surg; 2005 Oct; 42(4):726-33. PubMed ID: 16242561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.
    Levine MN; Hirsh J; Gent M; Turpie AG; Weitz J; Ginsberg J; Geerts W; LeClerc J; Neemeh J; Powers P
    Thromb Haemost; 1995 Aug; 74(2):606-11. PubMed ID: 8584992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation and improvement program for inpatient anticoagulant control.
    Phillips WS; Smith J; Greaves M; Preston FE; Channer KS
    Thromb Haemost; 1997 Feb; 77(2):283-8. PubMed ID: 9157582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting.
    Willey VJ; Bullano MF; Hauch O; Reynolds M; Wygant G; Hoffman L; Mayzell G; Spyropoulos AC
    Clin Ther; 2004 Jul; 26(7):1149-59. PubMed ID: 15336480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep vein thrombosis outcome and the level of oral anticoagulation therapy.
    Caprini JA; Arcelus JI; Reyna JJ; Motykie GD; Mohktee D; Zebala LP; Cohen EB
    J Vasc Surg; 1999 Nov; 30(5):805-11. PubMed ID: 10550177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts in anticoagulant therapy.
    Litin SC; Gastineau DA
    Mayo Clin Proc; 1995 Mar; 70(3):266-72. PubMed ID: 7861815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen.
    Siguret V; Gouin I; Debray M; Perret-Guillaume C; Boddaert J; Mahé I; Donval V; Seux ML; Romain-Pilotaz M; Gisselbrecht M; Verny M; Pautas E
    Am J Med; 2005 Feb; 118(2):137-42. PubMed ID: 15694897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge.
    Colwell CW; Collis DK; Paulson R; McCutchen JW; Bigler GT; Lutz S; Hardwick ME
    J Bone Joint Surg Am; 1999 Jul; 81(7):932-40. PubMed ID: 10428124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of acute symptomatic deep vein thrombosis.
    Heit JA
    Am J Cardiovasc Drugs; 2001; 1(1):45-50. PubMed ID: 14728051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.